Ontario will soon cover a combination HIV prevention pill that is now available in generic form, HIV advocates say.
The once-daily pill contains two anti-HIV drugs that reduce the risk of sexual transmission in HIV-negative individuals.
Pre-exposure prophylaxis, or PrEP, originally cost about $1,000 a month as the brand name Truvada. The drug was first introduced to treat HIV.
Ontario’s Health Ministry added the PrEP drug to its formulary of publicly covered drugs on Thursday, effective Sept. 28.
In 2016, Health Canada approved Truvada (emtricitabine 200mg/tenofovir disoproxil fumarate 300mg) in combination with safer sex practices to reduce the risk of sexually acquired HIV among adults at high risk of exposure to the virus. 
Since then, generics costing a quarter as much have become available, said pharmacist Michael Fanous in Toronto. 
“The generics are now at 450 per month and there are others entering the market at half that price,” Fanous said.
More people will now have access to the drug in more places, …
READ MORE ON WWW.CBC.CA